Stocks of Glenmark Pharmaceuticals Ltd sell on the target price of 525.0 with stoploss
Rs. 556
For Stocks of Glenmark Pharmaceuticals Ltd,Market Expert Manas Jaiswal suggests that Glenmark Pharmaceuticals Ltd Sell the shares at the target price of 525.0 because the Glenmark Pharmaceuticals Ltd The current market price of Rs 544.3. Market Expert has set its timeframe Intra Day, when Glenmark Pharmaceuticals Ltd The price can reach its set target. Manas Jaiswal has instructed investors to keep the stoploss Rs 556 and strictly follow it.
Glenmark Pharmaceuticals Ltd., active in the pharmaceuticals and health care sector, is a mid-cap company incorporated in the year 1977 (market cap - Rs 15444.47 crore).
For the end quarter 31-12-2018, organized sales report by the company - Rs 2509.78 crores, -1.18% down, last quarter sales - from Rs 2539.86 crores, and 15.58% over the same quarter last year sales - Rs 2171.50 Million In the latest quarter, the company has a net profit of Rs 116.34 crores after the reported tax.
On 31-03-2019, the company's total, 282,168,156 shares are outstanding.
Rs. 556
Glenmark Pharmaceuticals Ltd., active in the pharmaceuticals and health care sector, is a mid-cap company incorporated in the year 1977 (market cap - Rs 15444.47 crore).
For the end quarter 31-12-2018, organized sales report by the company - Rs 2509.78 crores, -1.18% down, last quarter sales - from Rs 2539.86 crores, and 15.58% over the same quarter last year sales - Rs 2171.50 Million In the latest quarter, the company has a net profit of Rs 116.34 crores after the reported tax.
On 31-03-2019, the company's total, 282,168,156 shares are outstanding.
No comments:
Post a Comment